Person who experienced the adverse event (patient)
Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5002271 | 6032375 | F | 1 | 5002271-X | 20000227 | 20060502 | 20060512 | EXP | GXKR2006DE01734 | SANDOZ INC., BROOMFIELD SITE | 85 | YR | F | N | 77 | KG | 20060510 | MD | GERMANY |
Drug(s) used by person
Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
---|---|---|---|---|---|---|---|---|---|---|---|
5002271 | 1007286233 | PS | MONO-EMBOLEX 8000 IE (CERTOPARIN SODIUIM)8000IU | 2 | SUBCUTANEOUS | 8000 IU, BID, SUBCUTANEOUS | Y | D | 40118 | ||
5002271 | 1007318824 | SS | ACETYLSALICYLIC ACID (NGX) (ACETYLSALICYLIC ACID) 100 MG | 2 | 1 DF, QD | D | D | ||||
5002271 | 1007318825 | C | AMLOCARD 10 (AMLODIPINE BESILATE) | 2 | |||||||
5002271 | 1007318826 | C | COAPROVEL 300/12.5 (HYDROCHLOROTHIAZIDE, IRBESARTAN) | 2 | |||||||
5002271 | 1007318827 | C | PENTALONG 50 (PENTAERITHRITYL TETRANITRATE) | 2 | |||||||
5002271 | 1007318828 | C | TORACARD 10 (TORASEMIDE) | 2 | |||||||
5002271 | 1007318829 | C | BISOPROLOL 10 (BISOPROLOL) | 2 |
Indications of drugs used
Event ID | DRUG SEQ | INDI PT |
---|---|---|
5002271 | 1007286233 | THROMBOSIS |
Outcome of event
Event ID | OUTC COD |
---|---|
5002271 | HO |
Reactions reported
Event ID | PT |
---|---|
5002271 | COMPARTMENT SYNDROME |
5002271 | HAEMATOMA |
Reporting Sources (this data is often not reported and may therefore be missing here)
Event ID | RPSR COD |
---|---|
5002271 | CR |
5002271 | FGN |
5002271 | HP |
5002271 | OTH |
Therapies reported
Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|
5002271 | 1007286233 | 20060220 | 20060228 | ||
5002271 | 1007318824 | 20060221 |